This inventor holds 2 USPTO granted patents. Top assignees: Bayer Corporation, Bayer Healthcare LLC. Active years: 2003-2009.
Company Filing History:
Years Active: 2003-2009
Title: Innovations of Robert W Kozak in Transmissible Spongiform Encephalopathy Detection
Introduction
Robert W Kozak is an accomplished inventor based in Foster City, CA (US). He has made significant contributions to the field of biomedical research, particularly in the detection of transmissible spongiform encephalopathy (TSE) proteins. With a total of 2 patents, his work has advanced the understanding and management of prion diseases.
Latest Patents
Kozak's latest patents include a method for the detection of TSE proteins employing a highly sensitive Western blot assay and chemiluminescent detection system. This invention provides a rapid and sensitive immunoassay capable of detecting and quantifying pathogenic proteins to a level of 3 to 5 logs. The preferred immunoassay utilized is a chemiluminescent endpoint for a Western blot immunoassay. This invention has been successfully applied to track the clearance of pathogenic proteins during the production of proteins derived from plasma. It is particularly applicable and has been confirmed by bioassay to relate TSE infectivity to quantitative results on prion protein.
Another notable patent is a rapid method for determining the clearance of prion protein. Transmissible spongiform encephalopathies (TSEs) are fatal neurodegenerative diseases found in many mammalian species. These diseases are caused by prions and display characteristic amyloid plaque deposition. The claimed invention is directed toward a rapid, specific, sensitive, and quantitative method for the detection of TSE clearance from a plasma product utilizing a chemiluminescent Western blot immunoassay. This immunoassay format can detect picogram concentrations of PrP and is linear over a 3-5 log range. The invention is useful for tracking the clearance of PrP during plasma manufacturing processes.
Career Highlights
Throughout his career, Robert W Kozak has worked with prominent organizations, including Bayer Corporation and Bayer Healthcare LLC. His expertise in the field has led to significant advancements in the detection and management of prion diseases.
Collaborations
Kozak has collaborated with notable colleagues such as Steve R Petteway and Douglas C Lee. Their combined efforts have contributed to the development of innovative solutions in the biomedical field.
Conclusion
Robert W Kozak's contributions to the detection of transmissible sp